Perigon Wealth Management LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 900 shares of the medical equipment provider’s stock after selling 235 shares during the period. Perigon Wealth Management LLC’s holdings in Intuitive Surgical were worth $513,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in ISRG. TFG Advisers LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $25,000. 1776 Wealth LLC grew its position in Intuitive Surgical by 72.2% in the 1st quarter. 1776 Wealth LLC now owns 62 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 26 shares during the period. Red Door Wealth Management LLC purchased a new stake in Intuitive Surgical during the 1st quarter valued at $33,000. Gemmer Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 89.7% during the 1st quarter. Gemmer Asset Management LLC now owns 74 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 35 shares during the period. Finally, Jacobi Capital Management LLC boosted its stake in shares of Intuitive Surgical by 59.1% in the 2nd quarter. Jacobi Capital Management LLC now owns 140 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 52 shares during the last quarter. Institutional investors own 87.24% of the company’s stock.
A number of research firms have weighed in on ISRG. Bank of America reissued a “buy” rating and issued a $650.00 target price on shares of Intuitive Surgical in a report on Thursday, April 9th. Sanford C. Bernstein increased their price objective on shares of Intuitive Surgical from $625.00 to $725.00 and gave the stock an “outperform” rating in a research note on Monday, July 20th. UBS Group lifted their target price on Intuitive Surgical from $565.00 to $670.00 and gave the company a “neutral” rating in a research report on Wednesday, July 22nd. BTIG Research reiterated a “hold” rating on shares of Intuitive Surgical in a research report on Friday, April 17th. Finally, Canaccord Genuity increased their target price on Intuitive Surgical from $562.00 to $725.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. Intuitive Surgical presently has a consensus rating of “Buy” and an average price target of $660.67.
In other Intuitive Surgical news, Director Amal M. Johnson sold 3,000 shares of the business’s stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $550.00, for a total transaction of $1,650,000.00. Following the sale, the director now owns 12,468 shares in the company, valued at approximately $6,857,400. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP David J. Rosa sold 17,950 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $553.49, for a total value of $9,935,145.50. Following the completion of the transaction, the executive vice president now directly owns 37,269 shares in the company, valued at $20,628,018.81. The disclosure for this sale can be found here. Insiders have sold 35,515 shares of company stock valued at $21,147,697 over the last quarter. Insiders own 1.60% of the company’s stock.
Shares of ISRG stock opened at $685.44 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $360.50 and a fifty-two week high of $704.00. The firm has a market capitalization of $80.44 billion, a price-to-earnings ratio of 72.08, a PEG ratio of 11.96 and a beta of 0.93. The stock’s 50-day simple moving average is $601.51 and its 200-day simple moving average is $554.82.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, July 21st. The medical equipment provider reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.52. Intuitive Surgical had a net margin of 26.07% and a return on equity of 13.62%. The company had revenue of $852.10 million during the quarter, compared to analysts’ expectations of $675.15 million. During the same period last year, the business earned $3.25 EPS. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 7.17 earnings per share for the current year.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
See Also: Commodities
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.